TheraRadar
Data updated: May 26, 2026

BACTOCILL IN PLASTIC CONTAINER (oxacillin sodium)

Infectious Disease Approved 1989-10-26

BACTOCILL IN PLASTIC CONTAINER is indicated for the treatment of Staphylococcal Infections.

Source: FDA Label • Baxter
Jump to: Indications Approvals Trials Competitors Similar Safety Patents
1
Indication
--
Phase 3 Trials
36
Years on Market

Details

Status
Prescription
First Approved
1989-10-26
Routes
INJECTION
Dosage Forms
INJECTABLE

Companies

Baxter
Active Ingredient: OXACILLIN SODIUM

BACTOCILL IN PLASTIC CONTAINER Approval History

1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
28 FDA actions from 1989 to 2017
Feb 2017 SUPPL
Label · Labeling
FDA Letter Label
Jan 2015 SUPPL
Label · Labeling
FDA Letter Label
Feb 2014 SUPPL
Mfg · Manufacturing (CMC)

What BACTOCILL IN PLASTIC CONTAINER Treats

1 indications

BACTOCILL IN PLASTIC CONTAINER is approved for 1 conditions since its original approval in 1989. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Staphylococcal Infections
Source: FDA Label

BACTOCILL IN PLASTIC CONTAINER Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Indication competitors

4

Same indication, different mechanism — what else might this patient receive?

NALLPEN IN PLASTIC CONTAINER
Baxter
1989 1 indic.
NAFCILLIN SODIUM
Fresenius Kabi
1984 1 indic.
Unlock 2 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to BACTOCILL IN PLASTIC CONTAINER

3 of 4

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

CLEOCIN PHOSPHATE
CLINDAMYCIN PHOSPHATE
1 shared
Pfizer
Shared indications:
Staphylococcal Infections
LINCOCIN
LINCOMYCIN HYDROCHLORIDE
1 shared
PHARMACIA AND UPJOHN
Shared indications:
Staphylococcal Infections
NAFCILLIN SODIUM
NAFCILLIN SODIUM
1 shared
Fresenius Kabi
Shared indications:
Staphylococcal Infections
View all 4 similar drugs Pro
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

BACTOCILL IN PLASTIC CONTAINER FDA Label Details

Indications & Usage

FDA Label (PDF)

BACTOCILL IN PLASTIC CONTAINER is indicated for the treatment of Staphylococcal Infections.

Track BACTOCILL IN PLASTIC CONTAINER with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

FDA Approval: NDA050640 → Label: DailyMed → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.